Psychedelic Stocks,Shroom News Lexston Launches Psychedelic Mushroom Genetic Identification Test By Dennis Mutua January 25, 2022 Biotechnology company engaging in contact based cannabis research and analytical testing to help licensed producers in cultivation, processing and extraction of naturally derived compounds Lexston Life Sciences Corp. (CSE: LEXT) (...
Featured,Trends & Articles Psychedelic Company Eleusis to go Public via Merger Deal With SPAC Silver Spike Acquisition Corp. II By Dennis Mutua January 24, 2022 Biotechnology company focused on transforming psychedelics into medicines Eleusis Inc. will be going public after a merger deal with a publicly traded special purpose acquisition company (SPAC) known as Silver Spike Acquisition Co...
Psychedelic Stocks Oregon Psilocybin: Business Issues, Part 2 By Dennis Mutua January 21, 2022 Welcome to the second installment in this series surveying business and regulatory issues for Oregon psilocybin program players. In part one, I covered the general process and schedule of Oregon Health Authority (OHA) rulemaking, ...
Featured,Shroom News Psygen Granted License to Become First Dedicated Psychedelics Manufacturing Facility in Canada By Dennis Mutua January 21, 2022 Manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications Psygen Labs announced having been granted a dealer’s license by Heath Canada to become Canada’s first dedicated ...
Spotlight Stock,Trends & Articles Awakn Life Sciences Inks MOU With MAPS By Dennis Mutua January 20, 2022 Biotechnology company focusing on research, development and delivery of psychedelic medicine to treat addictions Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) announced having signed a Memorandum of Understanding (MOU) with...
Spotlight Stock,Trends & Articles HaluGen Life Sciences Enters Into an Agreement With Psychedelics Today By Dennis Mutua January 19, 2022 Genetic based psychedelic pre-screening platform focusing on evaluating sensitivity and the risk profile when one is using hallucinogenic drugs HaluGen Life Sciences Inc. announced having entered in an agreement with Psychedelic T...
Psychedelic Stocks Washington Psilocybin Legalization: A Business Primer By Dennis Mutua January 18, 2022 On January 6, lawmakers filed Washington psilocybin legalization bill, SB 5660, the Washington Psilocybin Services Wellness and Opportunity Act. Two attorneys in our law firm’s psychedelics practice, Mason Marks and John Rapp, h...
Featured,Trends & Articles Filament Health and Cybin Therapeutics Enters Into a Licensing Agreement By Dennis Mutua January 18, 2022 Clinical-stage natural psychedelic drug development company supporting treatment of mental health conditions Filament Health Corp. (NEO: FH) (OTCQB: FHLLF) announced having entered into a licensing agreement with Cybin Therapeutic...